allergic bronchopulmonary aspergillosis abpa disease resulting hypersensitivity response aspergillus fumigatus pathogenesis disease unknown prevalence cystic fibrosis cf poorly defined data epidemiologic registry cystic fibrosis ercf NUMBER cf patients gathered NUMBER cf centres european countries analysed ercf definition abpa diagnosis positive skin test serum precipitins fumigatus serum immunoglobulin ige levels NUMBER u x additional clinical laboratory parameters overall prevalence abpa ercf population NUMBER range NUMBER sweden NUMBER belgium prevalence low NUMBER yrs age constant approximately NUMBER sex differences observed abpa affected NUMBER patients genotype deltaf508g542x genotypes abpa patients presented lower forced expiratory volume second fev1 abpa age prevalence ranged NUMBER patients fev1 fev1 NUMBER abpa associated higher rates microbial colonization pneumothorax massive haemoptysis higher igg serum levels poorer nutritional status mixed model regression analysis lung function showed fevi decline period substantially different abpa patients compared patients subgroups based age disease severity enrollment conclude allergic bronchopulmonary aspergillosis frequent complication cystic fibrosis patients particularly age NUMBER yrs generally associated poorer clinical condition clear independent influence allergic bronchopulmonary aspergillosis rate lung function decline short term shown ml NUMBER NUMBER NUMBER NUMBER NUMBER follow non abpa deltaf508 deltaf508 deltaf508 g551d deltaf508 n1303k